Teligent, Inc, a specialty generic pharmaceutical company, develops, manufactures, markets, and sells generic topical, branded generic, and generic injectable pharmaceutical products in the United States and Canada. It offers generic pharmaceutical products in topical, injectable, complex, and ophthalmic dosage forms. The company is also involved in contract manufacturing and development business, including the development, manufacturing, filling, and package of topical semi-solid and liquid products for branded and generic pharmaceutical customers, as well as for over-the-counter and cosmetic markets.
Read More…
Industry, Sector and Symbol
Industry Pharmaceutical preparations
Sub-IndustryN/A
SectorMedical
Phone856-697-1441
Debt
Price-To-Earnings
Sales & Book Value
Annual Sales$65.86 million
Profitability
Miscellaneous
Employees189
Next Earnings Date3/16/2020 (Estimated)
OptionableOptionable
Teligent (NASDAQ:TLGT) Frequently Asked Questions
What is Teligent's stock symbol?
Teligent trades on the NASDAQ under the ticker symbol "TLGT."
How were Teligent's earnings last quarter?
Teligent Inc (NASDAQ:TLGT) announced its quarterly earnings results on Monday, November, 4th. The company reported ($0.04) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.03) by $0.01. The company earned $18.47 million during the quarter, compared to the consensus estimate of $19.82 million. Teligent had a negative return on equity of 232.25% and a negative net margin of 51.29%. View Teligent's Earnings History.
When is Teligent's next earnings date?
What is the consensus analysts' recommendation for Teligent?
1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Teligent in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Teligent.
Has Teligent been receiving favorable news coverage?
News headlines about TLGT stock have trended very negative on Wednesday, according to InfoTrie Sentiment Analysis. The research group scores the sentiment of press coverage by monitoring more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. Teligent earned a news sentiment score of -3.3 on InfoTrie's scale. They also gave news stories about the company a news buzz of 10.0 out of 10, indicating that recent press coverage is extremely likely to have an impact on the company's share price in the near future. View News Stories for Teligent.
Are investors shorting Teligent?
Teligent saw a decrease in short interest during the month of January. As of January 31st, there was short interest totalling 6,220,000 shares, a decrease of 14.0% from the January 15th total of 7,230,000 shares. Based on an average daily volume of 455,100 shares, the days-to-cover ratio is presently 13.7 days. Approximately 14.3% of the shares of the stock are sold short. View Teligent's Current Options Chain.
Who are some of Teligent's key competitors?
Some companies that are related to Teligent include Monopar Therapeutics (MNPR), Eton Pharmaceuticals (ETON), Chimerix (CMRX), ESSA Pharma (EPIX), Otonomy (OTIC), Savara (SVRA), Trevi Therapeutics (TRVI), Vaccinex (VCNX), REDHILL BIOPHAR/S (RDHL), Aquestive Therapeutics (AQST), Sunesis Pharmaceuticals (SNSS), Proteostasis Therapeutics (PTI), Axovant Gene Therapies (AXGT), Checkpoint Therapeutics (CKPT) and Enlivex Therapeutics (ENLV).
What other stocks do shareholders of Teligent own?
Who are Teligent's key executives?
Teligent's management team includes the folowing people:
- Mr. Jason Grenfell-Gardner M.B.A., M.B.A, Pres, CEO & Director (Age 44)
- Mr. Stephen Richardson, Chief Scientific Officer (Age 53)
- Mr. Martin Wilson, Gen. Counsel (Age 42)
- Mr. Damian Finio, Corp. Sec. & CFO (Age 49)
- Ms. Nadya Lawrence, Sr. VP of Technical Services (Age 50)
Who are Teligent's major shareholders?
Teligent's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Sanders Morris Harris LLC (3.90%), Wedbush Securities Inc. (0.21%), Private Advisors LLC (0.17%), Spark Investment Management LLC (0.17%) and Virtu Financial LLC (0.13%). Company insiders that own Teligent stock include Bhaskar Chaudhuri, Carole Ben-Maimon, Damian Finio, James C Gale, Jason Grenfell-Gardner and Stephen Richardson. View Institutional Ownership Trends for Teligent.
Which major investors are selling Teligent stock?
TLGT stock was sold by a variety of institutional investors in the last quarter, including Sanders Morris Harris LLC, Spark Investment Management LLC and Private Advisors LLC. View Insider Buying and Selling for Teligent.
Which major investors are buying Teligent stock?
TLGT stock was bought by a variety of institutional investors in the last quarter, including Wedbush Securities Inc. and Virtu Financial LLC. Company insiders that have bought Teligent stock in the last two years include Bhaskar Chaudhuri, Carole Ben-Maimon, Damian Finio, James C Gale, Jason Grenfell-Gardner and Stephen Richardson. View Insider Buying and Selling for Teligent.
How do I buy shares of Teligent?
Shares of TLGT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.
What is Teligent's stock price today?
One share of TLGT stock can currently be purchased for approximately $0.47.
How big of a company is Teligent?
Teligent has a market capitalization of $25.33 million and generates $65.86 million in revenue each year. The company earns $-36,260,000.00 in net income (profit) each year or ($0.33) on an earnings per share basis. Teligent employs 189 workers across the globe.View Additional Information About Teligent.
What is Teligent's official website?
How can I contact Teligent?
Teligent's mailing address is 105 LINCOLN AVENUE, BUENA NJ, 08310. The company can be reached via phone at 856-697-1441 or via email at [email protected]
MarketBeat Community Rating for Teligent (NASDAQ TLGT)
MarketBeat's community ratings are surveys of what our community members think about Teligent and other stocks. Vote "Outperform" if you believe TLGT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe TLGT will underperform the S&P 500 over the long term. You may vote once every thirty days.
